A heart surgeon who performed a revolutionary aortic valve replacement therapy on patients with heart valve failure undergoes ...

Edwards Lifesciences Corporation (EW), headquartered in Irvine, California, provides products and technologies for structural ...

Edwards Lifesciences Corp. engages in the ... Its products are categorized into three areas: Transcatheter Heart Valves, Surgical Structural Heart and Critical Care. The Transcatheter Heart ...

“The two had a conversation.” Starr convinced Edwards they needed a successful artificial heart valve first and they agreed to embark on an ambitious project, each offering expertise in their ...

Edwards Lifesciences (NYSE: EW), a medical technology company specializing in artificial heart valves, currently trades at $67 per share, about 50% lower than the peak level of $131 seen in December ...

The Galien Foundation recently announced the nominees for its "Best Medical Technology" Pix Galien USA awards.

Edwards Lifesciences today announced the launch in Europe of the SAPIEN 3 transcatheter pulmonary valve implantation (TPVI) system with Alterra adaptive prestent, expanding minimally invasive ...

Katie Szyman, who led Edwards Lifesciences Corp.’s Critical Care unit that was recently sold for $4.2 billion, says ...

It has been a blockbuster year for women's health as the federal government and medtech place special focus on the wellbeing ...

Edward Lifesciences' Critical Care divestiture bodes well for its Structural Heart portfolio. Yet, macroeconomic issues raise worry for its operations.

“We are proud of this high-quality clinical research to inform patients’ decisions about the treatment of their heart valve failure,” said Larry Wood, Edwards’ corporate vice president and ...